Authors: Giannakakis, T Ziras, N Kakolyris, S Mavroudis, D Androulakis, N Agelaki, S Parashos, M Sarra, E Dimou, T Hatzidaki, D Vlachonikolis, J Georgoulias, V

Citation: T. Giannakakis et al., Docetaxel in combination with carboplatin for the treatment of advanced non-small cell lung carcinoma: a multicentre phase I study, EUR J CANC, 36(6), 2000, pp. 742-747

Authors: Janinis, J Giannakakis, T Athanasiades, A Fountzilas, G Bafaloukos, D Kosmidis, P Nikolaides, K Pavlidis, N Skarlos, D

Citation: J. Janinis et al., A randomized open-label parallel-group study comparing ondansetron with ondansetron plus dexamethasone in patients with metastatic breast cancer receiving high-dose epirubicin. A Hellenic Cooperative Oncology Group study, TUMORI, 86(1), 2000, pp. 37-41

Authors: Kouroussis, C Xydakis, E Potamianou, A Giannakakis, T Kakolyris, S Agelaki, S Sara, E Malamos, N Alexopoulos, A Mavroudis, D Samonis, G Papadouris, S Georgoulias, V Panagos, G

Citation: C. Kouroussis et al., Front-line treatment of metastatic breast cancer with docetaxel and epirubicin: A multicenter dose-escalation study, ANN ONCOL, 10(5), 1999, pp. 547-552

Authors: Mavroudis, D Malamos, N Alexopoulos, A Kourousis, C Agelaki, S Sarra, E Potamianou, A Kosmas, C Rigatos, G Giannakakis, T Kalbakis, K Apostolaki, F Vlachonicolis, J Kakolyris, S Samonis, G Georgoulias, V

Citation: D. Mavroudis et al., Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: A multicenter phase II trial, ANN ONCOL, 10(2), 1999, pp. 211-215